Breaking News Instant updates and real-time market news.

OPHT

Ophthotech

$45.30

1.35 (3.07%)

09:32
10/06/16
10/06
09:32
10/06/16
09:32

Ophthotech price target lowered to $23 from $45 at Goldman

Goldman analyst Terence Flynn lowered Ophthotech's (OPHT) price target to $23 from $45 and reiterated his Sell rating. He revised is thesis on Ophthotech following Regeneron's (REGN) recent negative Phase II data for its co-formulation of Eylea with Rinucumab and is incrementally more cautious on success for Fovista currently in Phase III trials.

OPHT Ophthotech
$45.30

1.35 (3.07%)

06/02/16
JPMS
06/02/16
UPGRADE
Target $84
JPMS
Overweight
Ophthotech upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama upgraded Ophthotech to Overweight saying the Fovista phase 3 Lucentis combination studies reading out in Q4 have a very high probability of success. The analyst's base case assumes a four-plus letter gain in visual acuity compared to Lucentis monotherapy, resulting in 55%-60% share upside. His "homerun scenario," or five-plus letter, results in 150% share upside. He raised his price target for Ophthotech shares to $84 from $60.
09/09/16
LEER
09/09/16
NO CHANGE
LEER
Leerink updates therapeutics best ideas for 2016
In a note to investors this morning, Leerink has updated its best ideas for 2016 from the firm's five therapeutics analysts. The list includes Alexion (ALXN), Dermira (DERM), Intra-Cellular (ITCI), Sanofi (SNY), Allergan (AGN), Alnylam (ALNY), Innate Pharma (IPHYF), The Medicines Co. (MDCO), and Ophthotech (OPHT).
09/30/16
COWN
09/30/16
NO CHANGE
Target $60
COWN
Outperform
Ophthotech price target lowered to $60 from $80 at Cowen
Cowen analyst Tyler Van Buren said that Regeneron's (REGN) Phase 2 data for aflibercept co-formulated with rinucumab is negative for the class of anti-PDGFs as a whole and lowered his price target on Ophthotech (OPHT) to $60 from $80 after lowering his view of the probability of the success of its own wet AMD treatment to 50%. However, if a 3-4 letter benefit if observed when the Phase III trials read out in December, upside of $80-$120 per share from current levels is still possible, said Van Buren, who keeps an Outperform rating on Ophthotech shares.
10/04/16
JPMS
10/04/16
NO CHANGE
Target $110
JPMS
Overweight
Ophthotech price target raised to $110 from $95 at JPMorgan
JPMorgan analyst Anupam Rama raised his price target for Ophthotech to $110 from $95 citing the elimination of Regeneron (REGN) from the Wet age-related macular degeneration space following its trial failure. Ophthotech closed yesterday down $2.56 to $43.57. The stock is down 20% since last Friday amid mechanism concerns following Regeneron's phase 2 data, Rama tells investors in a research note. The analyst views the weakness in Ophthotech as a buying opportunity. There are important mechanistic differences between the company's Fovista and Regeneron's REGN2176-3, and early phase 1 data for Fovista "are comparatively more compelling," the analyst contends. He points out that the Phase 3 results with Fovista + Lucentis combination therapy are expected this quarter. The analyst keeps an Overweight rating on Ophthotech.

TODAY'S FREE FLY STORIES

16:37
04/27/17
04/27
16:37
04/27/17
16:37
General news
Money Supply M2 Weekly Change data reported »

Week of 4/17 Money Supply…

16:36
04/27/17
04/27
16:36
04/27/17
16:36
General news
Fed Balance Sheet Level data reported »

Week of 4/26 Fed Balance…

RMD

ResMed

$72.85

1.1 (1.53%)

16:36
04/27/17
04/27
16:36
04/27/17
16:36
Earnings
ResMed reports Q3 non-GAAP EPS 71c, consensus 71c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 06

    Jun

HEP

Holly Energy

16:35
04/27/17
04/27
16:35
04/27/17
16:35
Hot Stocks
Holly Energy raises quarterly distribution 7.8% to 62c per unit »

The board of directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

BIDU

Baidu

$187.86

1.19 (0.64%)

16:35
04/27/17
04/27
16:35
04/27/17
16:35
Hot Stocks
Baidu reports 451,000 active online marketing customers in Q1 »

Representing a 23.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MOBL

MobileIron

$4.45

-0.05 (-1.11%)

16:35
04/27/17
04/27
16:35
04/27/17
16:35
Earnings
Breaking Earnings news story on MobileIron »

MobileIron backs FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    Jun

LPLA

LPL Financial

$38.52

-0.84 (-2.13%)

16:35
04/27/17
04/27
16:35
04/27/17
16:35
Hot Stocks
Breaking Hot Stocks news story on LPL Financial »

LPL Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 17

    May

MSFT

Microsoft

$68.27

0.44 (0.65%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Nadella says Q1 results reflect 'trust' in Microsoft Cloud »

"Our results this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 09

    May

MOBL

MobileIron

$4.45

-0.05 (-1.11%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Earnings
MobileIron sees Q2 revenue $42.5M-$44.5M, consensus $43.83M »

Non-GAAP gross margin is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    Jun

BIDU

Baidu

$187.86

1.19 (0.64%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Baidu CFO Jennifer Li to step down »

Baidu also announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

URBN

Urban Outfitters

$23.15

-0.55 (-2.32%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Urban Outfitters announces changes to store leadership »

Urban Outfitters, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INT

World Fuel Services

$36.79

-0.31 (-0.84%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Earnings
World Fuel Services reports Q1 adjusted EPS 64c, consensus 49c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

IPAR

Inter Parfums

$36.95

0.2 (0.54%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Inter Parfums says doesn't expect Q1-type growth in remaining quarter »

""First quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOBL

MobileIron

$4.45

-0.05 (-1.11%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Earnings
MobileIron reports Q1 non-GAAP EPS (6c), consensus (8c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    Jun

IPAR

Inter Parfums

$36.95

0.2 (0.54%)

16:33
04/27/17
04/27
16:33
04/27/17
16:33
Earnings
Inter Parfums backs FY17 EPS $1.20-$1.24, consensus $1.25 »

Backs FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MERC

Mercer

$12.55

0.1 (0.80%)

16:33
04/27/17
04/27
16:33
04/27/17
16:33
Earnings
Mercer reports Q1 EPS 15c, consensus 28c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

SGMS

Scientific Games

$22.80

-0.1 (-0.44%)

16:33
04/27/17
04/27
16:33
04/27/17
16:33
Earnings
Scientific Games reports Q1 EPS ($1.14), consensus (72c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 30

    May

VDSI

VASCO Data Security

$13.60

-0.05 (-0.37%)

16:32
04/27/17
04/27
16:32
04/27/17
16:32
Earnings
Breaking Earnings news story on VASCO Data Security »

VASCO Data Security sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

IPAR

Inter Parfums

$36.95

0.2 (0.54%)

16:32
04/27/17
04/27
16:32
04/27/17
16:32
Earnings
Inter Parfums reports Q1 revenue $143.1M, consensus $120.19M. »

"The 57% increase in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VDSI

VASCO Data Security

$13.60

-0.05 (-0.37%)

16:32
04/27/17
04/27
16:32
04/27/17
16:32
Earnings
VASCO Data Security reports Q1 non-GAAP EPS 8c, consensus (3c) »

Reports Q1 revenue $42M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

LRN

K12

$20.26

-0.17 (-0.83%)

16:32
04/27/17
04/27
16:32
04/27/17
16:32
Earnings
K12 sees Q4 revenue $215M-$220M, consensus $223.96M »

Sees Q4 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

EHTH

eHealth

$11.74

0.23 (2.00%)

16:31
04/27/17
04/27
16:31
04/27/17
16:31
Earnings
Breaking Earnings news story on eHealth »

eHealth sees FY17 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 10

    May

  • 30

    May

  • 06

    Jun

BIDU

Baidu

$187.86

1.19 (0.64%)

16:31
04/27/17
04/27
16:31
04/27/17
16:31
Earnings
Baidu sees Q2 revenue $2.974B-$3.048B, consensus $3.03B »

Representing an annual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

LRN

K12

$20.26

-0.17 (-0.83%)

16:31
04/27/17
04/27
16:31
04/27/17
16:31
Earnings
K12 reports Q3 EPS 23c, consensus 25c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

16:31
04/27/17
04/27
16:31
04/27/17
16:31
Options
Preliminary option volume of 15.6M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.